Chris Hill
Analyst · JPMorgan. Please go ahead
Thanks, David. One of the focal points in many of our discussions that began in early March has been around our corporate debt structure and the associated financial covenants. So we changed the format of today’s financial overview to include some comments to address these points of interest. I’ll first summarize the company's current liquidity position, our two primary debt instruments and the associated financial covenants. Then, I will provide the overview of our operational performance for the first quarter, material items in the balance sheet and cash flow. I would like to start off by saying we understand some of the differences between prior downturns in the industry and what has been caused today by the global COVID-19 pandemic. However, it is still important to understand that Core Lab was one of the few oilfield service companies which was able to remain profitable and generate free cash flow throughout the last downturn, which is also pretty severe. It is this history our light-asset business model and company culture that provides our organization with the confidence that we will continue to generate positive free cash flow and maintain our profitability through the current challenges. Core continues to utilize its $300 million revolving credit facility under which we had 154 million outstanding as of March 31, 2020, and the ability to draw an additional 131 million if needed. However, we are not projecting the need to borrow additional funds against our credit facility. In fact, with the changes to our future dividend policy, reduced capital needs and the cost reduction initiatives announced and implemented, our projections indicate a reduction of outstanding debt. For clarity, I’m going to repeat the cost reduction plans that we have quantified in the earnings release, have been approved, are within management’s control and are near completion as we are speaking today. Core Lab has two primary debt instruments; a revolving credit facility, just described, and the private placement notes that were issued back in 2011. Both of these unsecured debt instruments carry some financial covenants which are a restriction to the company’s leverage ratio and the company must maintain a minimum interest coverage ratio. The minimum interest coverage ratio permitted is 3x and is consistent across both debt instruments. Leverage ratio calculations are different for each instrument. The note used a traditional net debt to EBITDA calculation which is restricted to the ratio of 3.5. The revolving credit facility uses a modified calculation for adjusted EBITDA which adds back non-cash charges and expenses such as the impairment of goodwill and stock compensation. The leverage ratio under the credit facility agreement is restricted to a ratio of 2.5, and historically has been the most restrictive financial debt covenant for Core Lab. For the first quarter of 2020, Core Lab was able to reduce net debt by 6 million and also maintain its leverage ratio as calculated under the revolving credit agreement to 1.93 as of March 31, 2020. The company also continues to have a good relationship with our bank group and an open line of communication. The factors described above, the cost reduction initiatives implemented by the organization and the company's ability to remain profitable and continue generating positive free cash flow are all positive indicators that Core Lab is and will continue to be in a much stronger financial position than many other companies within the energy sector. Now with regards to our financial performance this quarter. The guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. Additionally, the financial results for first quarter of 2020 include charges of 122 million or impairment of goodwill and intangible assets associated with our production enhancement segment, 6.8 million for the acceleration of stock compensation expense associated with employees who have reached their eligible retirement age and an additional 1.2 million as we expanded our cost reduction plans in the first quarter. These items have been excluded from financial results to provide a more clear understanding of the performance from the underlying operations. Now looking at the income statement. Revenue from continuing operations was 152.4 million in the first quarter, down about 3% from 156.8 million in the fourth quarter of 2019. Our international business remained steady. However, as commodity prices weakened early in the quarter and fell sharply in March, the onshore activity was weaker than originally forecast. Revenue was also impacted by the disruptions associated and caused by the global COVID-19 pandemic, and after these events revenue would have challenged our original forecast for the first quarter. Of this revenue, service revenue which is more international was 110 million for the quarter, down from 115.2 million or about 4.5% sequentially. Our international revenue grew 1.5% sequentially. However, this was offset by a 9% decline in revenue sourced from the U.S. The decline in the U.S. was primarily associated with the drop in U.S. onshore activities. However, some delays on international projects and in international facilities were also experienced as a result of the global COVID-19 pandemic, which have continued into the second quarter. Product sales, which are tied more to North American activity, were 42.4 million for the quarter, an increase of 2% from 41.6 million last quarter. International product sales increased over last quarter which was partially offset by the decline in product sales to the U.S. onshore market, but completion activity levels were down significantly from last quarter. Some product sales to our international customers were delayed due to disruptions with airfreight carriers caused by the COVID-19 pandemic. Moving on to cost of services for the quarter are 74% of service revenue, up just slightly from 72% last quarter as service revenue declined slightly during the first quarter. When considering cost of services and the company's ability to generate very strong incremental margins, we have historically highlighted that the incremental cost to perform additional tests in our laboratories is very low or approximately 25%. These costs would be considered direct variable costs of performing services for our clients through our laboratory network. This level of direct variable costs would also be fairly consistent for our field-based services. We are not including our employee cost in these direct variable costs. So changes in our workforce would be considered structural changes. Cost of sales in the fourth quarter was 81% of revenue, a slight improvement from 83% last quarter as product sales increased slightly and we were able to improve the absorption of our fixed costs. Product sales carry a higher direct variable cost component and generally would average 50% to 55% of sales, which is also important to understand when projecting future financial results for product sales across both our operating segments. G&A, ex-items for the quarter, was 13.1 million which is up from 10 million from last quarter. The increase in G&A for the quarter was primarily due to non-cash expenses associated with employee compensation plans. With the cost reductions announced this quarter, we anticipate G&A expense will be approximately $4 million lower than previous projections. Depreciation and amortization for the quarter was 5.4 million which is comparable to the last several quarters. In 2020, we would expect depreciation expense to be slightly lower when compared to prior year levels. And our capital expenditures are projected to be around 11 million. EBIT, ex-items for the quarter, was 20.6 million and continues to represent best-in-class EBIT margins of 14%. Our operating loss for the quarter on a GAAP basis was 109 million which includes the non-cash charge of 122 million for the impairment of goodwill and intangible assets and the other charges previously discussed. Income tax expense, ex-items and using an effective tax rate of 20%, for the quarter was 3.4 million. On a GAAP basis, the company reported an income tax benefit of 4 million for the quarter. The income tax benefit is associated with the goodwill impairment charge. For the remainder of 2020, the effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and the impact of items discrete to each quarter. Income from continuing operations, ex-items, for the quarter was 13.7 million, down 20% sequentially from 17.1 million. GAAP operating loss from continuing operations was about 108 million for the first quarter. Earnings per diluted share from continuing operations, ex-items, was $0.31 for the quarter. The GAAP loss per share from continuing operations for the first quarter was $2.44. Now we’ll move on to the balance sheet. Receivables was 126.9 million and decreased 4.7 million from last quarter end. Our DSOs at 72 days for the quarter improved slightly from last quarter. We believe organizations across the globe were impacted, including ourselves, clients and the global banks as plans to work remotely were implemented and tested during Mark. We will continue to monitor our collections closely as we are currently not anticipating any significant changes in payment practices or behaviors from our client base. Inventory was 52.3 million, up a little over 2 million from year-end primarily due to the receded bulk raw materials during the quarter, as planned, and some delayed international shipments that were anticipated in March. Additionally, there were some unanticipated build in finished goods as activity dropped sharply in the U.S. onshore market as we exited the quarter. Our organization is working diligently to evaluate and assess the reduction of inventory balances throughout the remainder of 2020. This will take cooperation and coordination with some of our key vendors and suppliers. And now onto the liability side of the balance sheet. Our long-term debt at quarter end was 304 million and we reduced net debt by 6 million. As discussed earlier, our debt is comprised of our senior notes at 150 million as well as 154 million outstanding under our bank revolving credit facility. As stated earlier, management’s focus for the foreseeable future is to direct excess free cash towards reducing debt. Looking at cash flow. In the first quarter, cash flow from operating activities was 22 million. And after paying our 3.3 million in CapEx, our free cash flow in Q1 was 18.7 million, an increase of almost 13% sequentially. For 2020, the company anticipates that its CapEx will be down approximately 50% as compared to 2019. Our free cash flow conversion ratio, which is free cash flow divided by income from continuing operations, excluding non-cash charges and using a normalized 20% effective tax rate, was over 136% for the first quarter of 2020. This also marks the 74th consecutive quarter Core Lab has generated positive free cash flow, and we are projecting to continue generating positive free cash as we manage the organization through the challenging market ahead. We believe this is an important metric for shareholders when comparing company's financial results, particularly for those shareholders who utilize this counting cash flow models to assess valuations. I'll now turn it over to Gwen for an update on our outlook.